Compare · ASTH vs G
ASTH vs G
Side-by-side comparison of Astrana Health Inc. (ASTH) and Genpact Limited (G): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTH and G operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- G is the larger of the two at $5.90B, about 3.1x ASTH ($1.90B).
- Over the past year, ASTH is up 9.6% and G is down 29.2% - ASTH leads by 38.8 points.
- G has been more active in the news (15 items in the past 4 weeks vs 8 for ASTH).
- G has more recent analyst coverage (14 ratings vs 6 for ASTH).
- Company
- Astrana Health Inc.
- Genpact Limited
- Price
- $34.42+0.66%
- $34.85+0.27%
- Market cap
- $1.90B
- $5.90B
- 1M return
- +40.43%
- -6.37%
- 1Y return
- +9.62%
- -29.22%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2007
- News (4w)
- 8
- 15
- Recent ratings
- 6
- 14
Genpact Limited
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides supply chain design, planning, inventory optimization, transportation and logistics management, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, master data management, and other procurement and supply chain advisory services; and sales and commercial services in the lead-to-quote, quote-to-order, and customer service areas. In addition, the company offers IT services, which include end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. It serves banking, capital market, insurance, consumer goods, retail, life science, healthcare, high tech, and manufacturing and service industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.
Latest ASTH
- Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call
- SEC Form DEFA14A filed by Astrana Health Inc.
- SEC Form DEF 14A filed by Astrana Health Inc.
- SEC Form 4 filed by Basho Chandan
- Astrana Health, Inc. to Participate in Upcoming Investor Conferences
- SEC Form 4 filed by Lam Thomas S.
- SEC Form 4 filed by Sim Kenneth T.
- SEC Form 4 filed by Sim Brandon
- SEC Form 4 filed by Kumar Dinesh M.
- SEC Form 4 filed by Basho Chandan
Latest G
- Genpact Limited filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Genpact and HFS Research: 92% of Executives Say Agentic AI Will Fundamentally Change Business Operations
- Genpact Named a Leader in ISG Provider Lens™ 2026 ServiceNow Ecosystem Partners
- Director Hinshaw John M was granted 6,521 shares, increasing direct ownership by 279% to 8,855 units (SEC Form 4)
- Director Lindstrom Carol was granted 6,521 shares, increasing direct ownership by 31% to 27,706 units (SEC Form 4)
- Director Morken Cecelia was granted 6,521 shares, increasing direct ownership by 11% to 64,281 units (SEC Form 4)
- Director Gangestad Nicholas C was granted 6,521 shares, increasing direct ownership by 74% to 15,334 units (SEC Form 4)
- Director Verdi Mark A was granted 6,521 shares, increasing direct ownership by 10% to 71,526 units (SEC Form 4)
- Director Subaiya Thimaya K. was granted 6,521 shares, increasing direct ownership by 323% to 8,541 units (SEC Form 4)
- Director Stevens Brian Mark was granted 6,521 shares, increasing direct ownership by 22% to 36,619 units (SEC Form 4)